HealthDay on MSN
Inpatient Hepatitis C Consultation After Delivery Tied to Better Treatment Completion
Providing immediate bedside HCV consultation at discharge from labor and delivery for women with HCV-affected pregnancies is associated with higher rates of treatment completion than referral for ...
WHO’s classification of hepatitis D virus as carcinogenic raises urgent questions for vaccination, screening, and treatment ...
Providing immediate bedside hepatitis C virus (HCV) consultation at discharge from labor and delivery for women with HCV-affected pregnancies is associated with higher rates of treatment completion ...
Women who were prescribed direct-acting antivirals prior to hospital discharge were more likely to complete their regimens.
Discover a study on viral hepatitis screening, revealing how risk-based testing misses infections and why universal detection ...
Times-Standard on MSN
DHHS reports ‘drastic decrease’ in hepatitis C cases in past five years
Humboldt County’s Public Health brach gave a presentation on a 13-year-old syringe exchange, overdose prevention and harm ...
Public comment period opens for proposed Medicaid work requirements. Chippewa Cree Tribe awarded $2.5 million for hepatitis C treatment. Missoula County awarded $1.2 million for wildfire mitigation.
It's unusual for Presidents to give medical advise. But this week President Trump told parents to delay giving their kids a ...
All adults who have blood taken as part of their treatment will have the sample tested for HIV, hepatitis B and hepatitis C, ...
The Nation UAE on MSN
OGDC collaborates with AKUH to organise Hepatitis C elimination camps
Oil and Gas Development Company Limited (OGDC) has collaborated with Aga Khan University Hospital (AKUH) to organise a series of Hepatitis C Elimination Camps, offering free screening and treatment ...
In a press conference this week, President Trump said there's no reason to give babies the Hepatitis B vaccine. But pediatricians and infectious disease experts say this guidance is dangerous.
On Wednesday, 10 September 2025, Enanta Pharmaceuticals (NASDAQ:ENTA) presented at the Baird Global Healthcare Conference 2025, emphasizing its strategic advancements in virology and immunology. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results